Pacific Biosciences of California, Inc. (PACB)
NASDAQ: PACB · Real-Time Price · USD
1.140
-0.100 (-8.06%)
At close: Mar 28, 2025, 4:00 PM
1.130
-0.010 (-0.88%)
After-hours: Mar 28, 2025, 7:59 PM EDT

Company Description

Pacific Biosciences of California, Inc. designs, develops, and manufactures sequencing solution to resolve genetically complex problems.

The company provides sequencing systems; consumable products, including single molecule real-time (SMRT) technology; long-read sequencing; and various reagent kits designed for specific workflow, such as preparation kit to convert DNA into SMRTbell double-stranded DNA library formats, including molecular biology reagents, such as ligase, buffers, and exonucleases.

It also offers binding kits, such as modified DNA polymerase used to bind SMRTbell libraries to the polymerase in preparation for sequencing; and sequencing kits comprise reagents required for on-instrument, real-time sequencing, including the phospholinked nucleotides.

In addition, the company provides Revio, Vega, Sequel, Sequel II, and Sequel IIe instruments which conduct, monitor, and analyze single-molecule biochemical reactions in real time; SBB short-read sequencing; onso instrument conducts, monitors, and analyzes SBB biochemical reactions; and SBB consumable, including flow cells, clustering, and sequencing reagent kits.

It serves academic and governmental research institutions; commercial testing and service laboratories; genome centers; public health labs, hospitals and clinical research institutes, and contract research organizations; pharmaceutical companies; and agricultural companies.

The company markets its products through a sales force and distribution partners in Australia, certain parts of Asia, Europe, the Middle East, Africa, Central America, and South America.

The company was formerly known as Nanofluidics, Inc. and changed its name to Pacific Biosciences of California, Inc. in 2005.

Pacific Biosciences of California, Inc. was incorporated in 2000 and is headquartered in Menlo Park, California.

Pacific Biosciences of California, Inc.
Pacific Biosciences of California logo
Country United States
Founded 2000
IPO Date Oct 27, 2010
Industry Medical Devices
Sector Healthcare
Employees 575
CEO Christian O. Henry

Contact Details

Address:
1305 O’Brien Drive
Menlo Park, California 94025
United States
Phone 650 521 8000
Website pacb.com

Stock Details

Ticker Symbol PACB
Exchange NASDAQ
Stock Type Common Stock
Fiscal Year January - December
Reporting Currency USD
CIK Code 0001299130
CUSIP Number 69404D108
ISIN Number US69404D1081
Employer ID 16-1590339
SIC Code 3826

Key Executives

Name Position
Christian O. Henry M.B.A. President, Chief Executive Officer, Interim Chief Financial Officer and Director
Mark Van Oene Ph.D. Chief Operating Officer
Dr. Stephen Turner Ph.D. Co-Founder
Michele Farmer CPA Vice President and Chief Accounting Officer
Dr. Brett Atkins J.D., Ph.D. General Counsel and Corporate Secretary
David Ruggiero Global Head of Sales and Service
Natalie Welch Chief People Officer

Latest SEC Filings

Date Type Title
Mar 27, 2025 8-K Current Report
Mar 17, 2025 S-8 Securities to be offered to employees in employee benefit plans
Mar 17, 2025 10-K Annual Report
Mar 13, 2025 8-K Current Report
Mar 3, 2025 144 Filing
Mar 3, 2025 144 Filing
Feb 18, 2025 144 Filing
Feb 18, 2025 144 Filing
Feb 13, 2025 8-K Current Report
Feb 7, 2025 8-K/A [Amend] Current report